BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20230782)

  • 1. Discovery of novel antiviral agents directed against the influenza A virus nucleoprotein using photo-cross-linked chemical arrays.
    Hagiwara K; Kondoh Y; Ueda A; Yamada K; Goto H; Watanabe T; Nakata T; Osada H; Aida Y
    Biochem Biophys Res Commun; 2010 Apr; 394(3):721-7. PubMed ID: 20230782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication.
    Ozawa M; Fujii K; Muramoto Y; Yamada S; Yamayoshi S; Takada A; Goto H; Horimoto T; Kawaoka Y
    J Virol; 2007 Jan; 81(1):30-41. PubMed ID: 17050598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus Nucleoprotein.
    Kakisaka M; Sasaki Y; Yamada K; Kondoh Y; Hikono H; Osada H; Tomii K; Saito T; Aida Y
    PLoS Pathog; 2015 Jul; 11(7):e1005062. PubMed ID: 26222066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.
    Jiang H; Xu Y; Li L; Weng L; Wang Q; Zhang S; Jia B; Hu H; He Y; Jacob Y; Toyoda T
    Antivir Chem Chemother; 2011 Nov; 22(3):119-30. PubMed ID: 22095520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A classical bipartite nuclear localization signal on Thogoto and influenza A virus nucleoproteins.
    Weber F; Kochs G; Gruber S; Haller O
    Virology; 1998 Oct; 250(1):9-18. PubMed ID: 9770415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the N-terminal caspase cleavage site in the nucleoprotein of influenza A virus in vitro and in vivo.
    Lipatov AS; Yen HL; Salomon R; Ozaki H; Hoffmann E; Webster RG
    Arch Virol; 2008; 153(3):427-34. PubMed ID: 18058063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing and screening of universal drug from neem (Azadirachta indica) and standard drug chemicals against influenza virus nucleoprotein.
    Ahmad A; Javed MR; Rao AQ; Husnain T
    BMC Complement Altern Med; 2016 Dec; 16(1):519. PubMed ID: 27986088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale analysis of influenza A virus nucleoprotein sequence conservation reveals potential drug-target sites.
    Kukol A; Hughes DJ
    Virology; 2014 Apr; 454-455():40-7. PubMed ID: 24725930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel compound targeting the nuclear export of influenza A virus nucleoprotein.
    Huang F; Chen J; Zhang J; Tan L; Lu G; Luo Y; Pan T; Liang J; Li Q; Luo B; Zhang H; Lu G
    J Cell Mol Med; 2018 Mar; 22(3):1826-1839. PubMed ID: 29193684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of influenza A nucleoprotein body domain residues essential for viral RNA expression expose antiviral target.
    Davis AM; Ramirez J; Newcomb LL
    Virol J; 2017 Feb; 14(1):22. PubMed ID: 28173821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA.
    Ye Q; Krug RM; Tao YJ
    Nature; 2006 Dec; 444(7122):1078-82. PubMed ID: 17151603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligomerization of the influenza virus nucleoprotein: identification of positive and negative sequence elements.
    Elton D; Medcalf E; Bishop K; Digard P
    Virology; 1999 Jul; 260(1):190-200. PubMed ID: 10405371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of small molecule inhibitors for influenza a virus using in silico and in vitro approaches.
    Makau JN; Watanabe K; Ishikawa T; Mizuta S; Hamada T; Kobayashi N; Nishida N
    PLoS One; 2017; 12(3):e0173582. PubMed ID: 28273150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and application of monoclonal antibodies against avian influenza virus nucleoprotein.
    Yang M; Berhane Y; Salo T; Li M; Hole K; Clavijo A
    J Virol Methods; 2008 Feb; 147(2):265-74. PubMed ID: 18006085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening methods for influenza antiviral drug discovery.
    Atkins C; Evans CW; White EL; Noah JW
    Expert Opin Drug Discov; 2012 May; 7(5):429-38. PubMed ID: 22435452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using mutagenesis to explore conserved residues in the RNA-binding groove of influenza A virus nucleoprotein for antiviral drug development.
    Liu CL; Hung HC; Lo SC; Chiang CH; Chen IJ; Hsu JT; Hou MH
    Sci Rep; 2016 Feb; 6():21662. PubMed ID: 26916998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unconventional NLS is critical for the nuclear import of the influenza A virus nucleoprotein and ribonucleoprotein.
    Cros JF; GarcĂ­a-Sastre A; Palese P
    Traffic; 2005 Mar; 6(3):205-13. PubMed ID: 15702989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of a single siRNA against a conserved region of NP gene strongly inhibits in vitro replication of different Influenza A virus strains of avian and swine origin.
    Stoppani E; Bassi I; Dotti S; Lizier M; Ferrari M; Lucchini F
    Antiviral Res; 2015 Aug; 120():16-22. PubMed ID: 25986248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A highly conserved region of the Sendai virus nucleocapsid protein contributes to the NP-NP binding domain.
    Myers TM; Pieters A; Moyer SA
    Virology; 1997 Mar; 229(2):322-35. PubMed ID: 9126246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of an In-Cell Western assay for measurement of influenza A virus replication.
    Wan Y; Zhou Z; Yang Y; Wang J; Hung T
    J Virol Methods; 2010 Nov; 169(2):359-64. PubMed ID: 20709106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.